WALPOLE PHARMACEUTICALS LIMITED Financials
- Company number
- 04843395CopyCopy
- Registered office
- C/O MICHAEL LEONG AND COMPANY, 43 Overstone Road, London W6 0AD
- Incorporated
- 23/07/2003
Company snapshot
- Status
- Active
- Employees
- 7 (2025)
- Latest financial data
- 2025
- Accounts type
- Total Exemption Full
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
52.29%vs 20242024: £77.67K
Total Assets
13.57%vs 20242024: £304.18K
Cash in Bank
49.70%vs 20242024: £20.47K
Total Liabilities
0.07%vs 20242024: £225.92K
Employees
-2vs 20242024: 9
In 2025, WALPOLE PHARMACEUTICALS LIMITED reported net assets of £118.28K. The same filing shows total assets of £345.45K, cash in bank of £30.64K and total liabilities of £226.07K. Reported headcount was 7 in 2025. Total Assets rose from £304.18K in 2024 to £345.45K in 2025 (13.57%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
52.29%from £77.67K in 2024Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures WALPOLE PHARMACEUTICALS LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
+2.9%vs 2023+1.5% a year compound (CAGR)
Cash in Bank
-24.7%vs 2023-13.2% a year compound (CAGR)
Total Assets
+5.2%vs 2023+2.6% a year compound (CAGR)
Total Liabilities
+6.4%vs 2023+3.1% a year compound (CAGR)
Employees
Increasedvs 2023+7Biggest increase
Total Liabilities+6.4%
£212.54K in 2023 to £226.07K in 2025
Biggest decrease
Cash in Bank-24.7%
£40.68K in 2023 to £30.64K in 2025
WALPOLE PHARMACEUTICALS LIMITED's filings pull in both directions between 2023 and 2025. The steepest rise came in total liabilities, pointing to heavier outstanding obligations, set against a fall in cash in bank, pointing to a tighter cash position. See the full year-by-year figures.
Ratios from the filed figures
Calculated from WALPOLE PHARMACEUTICALS LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 34.24%2025
- Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
- Liabilities to total assets
- 65.44%2025
- Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
- Cash to liabilities
- 13.56%2025
- Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
- Cash to total assets
- 8.87%2025
- Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for WALPOLE PHARMACEUTICALS LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Assets£ | 194.90K | 190.35K | 114.91K | 77.67K | 118.28K |
| Total Assets£ | 438.10K | 406.64K | 328.29K | 304.18K | 345.45K |
| Cash in Bank£ | 65.59K | 102.16K | 40.68K | 20.47K | 30.64K |
| Total Liabilities£ | 241.98K | 214.37K | 212.54K | 225.92K | 226.07K |
| Employees | 6 | 7 | 0 | 9 | 7 |
WALPOLE PHARMACEUTICALS LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Yes. Okredo holds filed figures for WALPOLE PHARMACEUTICALS LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.
WALPOLE PHARMACEUTICALS LIMITED reported net assets of £118.28K for 2025. That compares with £77.67K in 2024, a change of 52.29%.
WALPOLE PHARMACEUTICALS LIMITED reported total assets of £345.45K for 2025. That compares with £304.18K in 2024, a change of 13.57%.
WALPOLE PHARMACEUTICALS LIMITED reported cash in bank of £30.64K for 2025. That compares with £20.47K in 2024, a change of 49.70%.
WALPOLE PHARMACEUTICALS LIMITED reported 7 employees in 2025, compared with 9 in 2024.
Between 2023 and 2025, WALPOLE PHARMACEUTICALS LIMITED's net assets rose by 2.9%, cash in bank fell by 24.7%, total assets rose by 5.2% and total liabilities rose by 6.4%. Net assets compounded at 1.5% a year across the two years to 2025, from £114.91K to £118.28K. Reported headcount went from 0 in 2023 to 7 in 2025 (+7).
Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.